Medivir AB (publ) 

SEK7.22
2
+SEK0+0% Monday 17:29

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

25AprExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.49
-0.42
-0.34
-0.27
Expected EPS
N/A
Actual EPS
N/A

Financials

-2,013.73%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
4.41MRevenue
-88.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MVIR-B.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.
Show more...
CEO
Mr. Magnus Christensen
Employees
9
Country
Sweden
ISIN
SE0000273294
WKN
000903662

Listings

0 Comments

Share your thoughts

FAQ

What is Medivir AB (publ) stock price today?
The current price of MVIR-B.ST is SEK7.22 SEK — it has increased by +0% in the past 24 hours. Watch Medivir AB (publ) stock price performance more closely on the chart.
What is Medivir AB (publ) stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medivir AB (publ) stocks are traded under the ticker MVIR-B.ST.
What is Medivir AB (publ) revenue for the last year?
Medivir AB (publ) revenue for the last year amounts to 4.41M SEK.
What is Medivir AB (publ) net income for the last year?
MVIR-B.ST net income for the last year is -88.77M SEK.
How many employees does Medivir AB (publ) have?
As of May 05, 2026, the company has 9 employees.
In which sector is Medivir AB (publ) located?
Medivir AB (publ) operates in the Health & Wellness sector.
When did Medivir AB (publ) complete a stock split?
Medivir AB (publ) has not had any recent stock splits.
Where is Medivir AB (publ) headquartered?
Medivir AB (publ) is headquartered in Huddinge, Sweden.